Golden Drugs Private Limited - Company Profile

Q: Where is Golden Drugs Private Limited headquartered?

Golden Drugs Private Limited is headquartered at 101, Laxmi Narayan Complex, 5Th Floor, Palace Road,, Bangalore, Karnataka, 560052.

Q: Who are the current directors of Golden Drugs Private Limited?

The current directors of Golden Drugs Private Limited are Ravindrakumar Kothari, Shailesh Dheerajmal Siroya.

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2012.

2012 Bangalore, Karnataka, India Amalgamated

Last Updated: July 06, 2025

Access Report

About Golden Drugs Private Limited

Golden Drugs Private Limited, a amalgamated private limited company, was established on 27 August 2012 in Bangalore, Karnataka, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232KA2012PTC157474. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹3.59 Cr.

Formerly known as Golden Drug Private Limited. It upholds a compliant status. Employing 80 professional, Its leadership includes Ravindrakumar Kothari (Director), Shailesh Dheerajmal Siroya (Director). Past directors included Ravindrakumar Kothari, Gulshan Jain Dalal, Snehlata Dalal. It holds ₹20.00 Cr open charges and ₹24.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 10/1, Laxmi Narayan Complex, 5Th Floor, Palace Road,, Bangalore, Karnataka, 560052.

Company Details

CIN/LLPIN
U24232KA2012PTC157474
Registration Number
157474
Incorporation Date
27 August 2012
Authorized Capital
₹4.50 Cr
Paid-Up Capital
₹3.59 Cr
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Amalgamated

Key Metrics

Authorised Capital ₹ 4.50 Cr as on 06-07-2025
Paid Up Capital ₹ 3.59 Cr as on 06-07-2025
Company Age 13 Year, 6 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 20.00 Cr as on 06-07-2025
Satisfied Charges ₹ 24.50 Cr as on 06-07-2025
Revenue Growth **** -21.62% (FY 2024)
Profit Growth **** 8.67% (FY 2024)
Ebitda **** 49.99% (FY 2024)
Net Worth -38.54% (FY 2024)
Total Assets -5.28% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Golden Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Golden Drugs Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ravindrakumar Kothari	Director	15 Nov 2018	Current
Shailesh Dheerajmal Siroya	Director	12 Apr 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	30 Sep 2019	Past
Pramod Abcsdd	Director	21 Jul 2016	Past
Pramod Abcsdd	Director	22 Mar 2018	Past
Pramod Abcsdd	Director	19 Nov 2018	Past
Pramod Abcsdd	Director	06 May 2016	Past
Pramod Abcsdd	Director	19 Nov 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Golden Drugs.

Golden Drugs Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 21.62% decrease. The company also saw a slight improvement in profitability, with a 8.67% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.54%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-21.62%

*******

Revenue from Operations

*******

-21.66%

*******

Total Assets

*******

-5.28%

*******

Profit or Loss

*******

8.67%

*******

Net Worth

*******

-38.54%

*******

EBITDA

*******

49.99%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Golden Drugs?

In 2024, Golden Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹200,000,000.00

Satisfied Charges

₹245,000,000.00

Charges Breakdown by Lending Institutions

Tata Capital Financial Services Limited : 15.00 Cr
Punjab National Bank : 9.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
28 Sep 2018	Tata Capital Financial Services Limited	₹15.00 Cr	Satisfied
15 Oct 2014	Punjab National Bank	₹4.00 Cr	Satisfied
15 Oct 2014	Punjab National Bank	₹5.50 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Golden Drugs?

Golden Drugs has a workforce of 80 employees as of Mar 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Golden Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Golden Drugs's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Golden Drugs

Recent Activity within the Organization

Annual General Meeting

Progress on Golden Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
30 Sep 2024
Balance Sheet

Golden Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
31 Mar 2024
Charges

A charge registered on 28 Sep 2018 via Charge ID 100207862 with Tata Capital Financial Services Limited was fully satisfied on 24 Jan 2024. was recorded as a recent event.
24 Jan 2024
Director Appointment

The activity Ravindrakumar Kothari was appointed as a Director was appointed as a Director on 15 Nov 2018 & has been associated with this company since 7 years 3 months . was completed.
15 Nov 2018
Charges

The activity A charge with Tata Capital Financial Services Limited of Rs. 15.00 Cr registered on 28 Sep 2018 with Charge ID 100207862 was modified on 17 Oct 2018. was completed.
17 Oct 2018
Charges

A charge with Tata Capital Financial Services Limited amounted to Rs. 15.00 Cr with Charge ID 100207862 was registered on 28 Sep 2018. was recorded as a recent event.
28 Sep 2018

Explore recent activity and updates - View Recent Activity